• RWD98 Hospital Burden of Pulmonary Arterial Hypertension in Fran A Real-World Study Using the French Hospitalization Database (PMSI)

    Dec 1, 2025, 00:00

  • HTA104 Delayed Impact, Limited Leverage: Revenue Dynamics of Patent-Protected Drugs and the Effectiveness of Price-Volume Agreements in Germany

    Dec 1, 2025, 00:00

  • SA71 Natural Language Processing for Identification of Negative Symptoms in Patients With and Without Cognitive Impairment Associated With Schizophrenia (CIAS)

    Dec 1, 2025, 00:00

  • HTA181 How the EU JCA Could Interface With Regional Pricing Alliances (BeNeLuxA, Nordic Forum, Valletta Group) and EU-Level Procurement Under the Critical Medicines Act

    Dec 1, 2025, 00:00

  • PCR45 Cognitive Debrief of the PROMIS Parent Proxy Mobility Item Bank in Caregivers of Children Living With Duchenne Muscular Dystrophy

    Dec 1, 2025, 00:00

  • MSR63 Cost-Effectiveness Modeling Based on a Clinical Trial Re-analysis Using Multimodal Machine Artificial Intelligence Methodology: Predicting Which Patients May Benefit Most From the Addition of Tremelimumab to Durvalumab Plus Chemothera ...

    Dec 1, 2025, 00:00

  • PCR264 Variability in Health Utility Scores in Pancreatic Cancer: Findings From a Targeted Literature Review

    Dec 1, 2025, 00:00

  • PCR44 CKDL5 Deficiency Disorder: Caregiver’s Perception of Clinical Symptoms Disease Management and Its Impact on Quality-of-life

    Dec 1, 2025, 00:00

  • EE159 Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland

    Dec 1, 2025, 00:00

  • EE696 The Costs of Loneliness-Related Health Consequences in Finland

    Dec 1, 2025, 00:00

  • PT38 Efficacy and Safety of Nalbuphine Compared With Analgesics for Moderate to Severe Postoperative Pain: A Systematic Review and Network Meta-Analysis

    Dec 1, 2025, 00:00

  • HTA250 Navigating Uncharted Waters: Challenge of Anticipating Technologies Subject to Environmental Considerations in Future HTA

    Dec 1, 2025, 00:00

  • EE726 The Socioeconomic Value of Adult Respiratory Immunization Programs in Fran Can Improved Coverage Unlock Missed Gains?

    Dec 1, 2025, 00:00

  • EPH187 Premature Mortality and Lost Productivity Due to HPV-Related Cancers in Europe

    Dec 1, 2025, 00:00

  • HTA125 Ensuring Greater Acceptance of Minimal Residual Disease Negativity in Health Technology Assessments in Multiple Myeloma: Key Barriers and Opportunities

    Dec 1, 2025, 00:00

  • HPR75 Evaluating the Costs and Benefits of Innovative Pricing and Payment Models in Europe

    Dec 1, 2025, 00:00

  • HTA87 Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease

    Dec 1, 2025, 00:00

  • RWD2 A Hierarchical Algorithm to Identify Pregnancy Start and Duration Using Structured EHR Data

    Dec 1, 2025, 00:00

  • SA45 Gaps in JCA Guidance for Systematic Literature Reviews: A Comparative Review with Cochrane, EUnetHTA, and Major HTA Agencies' Standards

    Dec 1, 2025, 00:00

  • EE481 Global Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • EPH140 Incidence and Prevalence of Primary Biliary Cholangitis (PBC) and Cholestatic Pruritus (CP) in Germany: Results From a Statutory Health Insurance (SHI) Claims Analysis

    Dec 1, 2025, 00:00

  • HTA169 Harnessing Generative Artificial Intelligence for Global Value Dossier Development

    Dec 1, 2025, 00:00

  • CO58 Comparative Efficacy of Iptacopan Monotherapy vs. Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC)

    Dec 1, 2025, 00:00

  • EPH10 A Systematic Literature Review to Identify Risk Factors and Symptoms of Long COVID-19 in Adult Indian Patients

    Dec 1, 2025, 00:00

  • EE1 Care Now, Pay Later (CNPL): Evaluating the Budgetary and Access Implications of a Novel Financing Model for Inclisiran in Atherosclerotic Cardiovascular Disease (ASCVD) Patients in India

    Dec 1, 2025, 00:00

  • EE151 Conceptualizing an Economic Model Structure for Parkinson's Disease

    Dec 1, 2025, 00:00

  • HPR198 The Effect of Pharmaceutical Pricing Policies on Healthcare Expenditures in Turkey: Analysis for the Period 2015-2024

    Dec 1, 2025, 00:00

  • HPR239 Which Country Is Currently Reporting the Lowest Global Prices for Semaglutide, and Why?

    Dec 1, 2025, 00:00

  • EE483 Has the IRA Impacted International Price Differentials? Comparing US and German Drug Prices in the Era of MFP

    Dec 1, 2025, 00:00

  • EPH100 Examining The Relationship Between Diabetes Mellitus and Eating Disorders

    Dec 1, 2025, 00:00

  • PT15 Development of the Eating Drivers Diary (EDDY): A Novel Patient-Reported Outcome Measure for Use in Clinical Trials of Medications for Weight Reduction

    Dec 1, 2025, 00:00

  • PCR83 Evaluating the Role of Disease-Specific Patient-Reported Outcomes in HTA Submissions for Rare Conditions: A Comparative Case Study of Narcolepsy and Phenylketonuria

    Dec 1, 2025, 00:00

  • PCR33 Bimekizumab Led to Sustained Improvements in Health-Related Quality of Life and Work Productivity in Patients With Axial Spondyloarthritis: 3-Year Results From Two Phase 3 Studies

    Dec 1, 2025, 00:00

  • RWD20 Assessing the Clinical and Economic Burden of Surgical Bleeding in Switzerland

    Dec 1, 2025, 00:00

  • EE89 Budget Impact Analysis of Introducing Nirsevimab Into the National Immunization Program for Infants in Korea

    Dec 1, 2025, 00:00

  • HPR105 From Promise to Practi Addressing the Systemic Challenges of Underinvestment in Prevention

    Dec 1, 2025, 00:00

  • CO225 Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of the First-Line (1L) Treatments of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Dec 1, 2025, 00:00

  • PCR30 Beyond the Conversation: A Narrative Review of Cost-Informed Shared Decision Making and Its Impact on Medication Adherence in Chronic Conditions

    Dec 1, 2025, 00:00

  • EPH219 Strong But Do They Ask for Help? Mental Health of Young Athletes

    Dec 1, 2025, 00:00

  • EPH156 Large Language Model (LLM) as Catalyst for Rapid and Efficient Critical Appraisal of Epidemiological Research

    Dec 1, 2025, 00:00

  • PCR43 Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers

    Dec 1, 2025, 00:00

  • RWD48 DARWIN EU® Characterizing Clinically Recognized Hypertrophic Cardiomyopathy in Six European Countries: A Descriptive Analysis Using Real-World Data

    Dec 1, 2025, 00:00

  • PCR241 The Reliability and Validity of the Greek Version of the Pediatric Quality of Life Inventory™ 30 Duchenne Muscular Dystrophy Module in Children With Duchenne Muscular Dystrophy

    Dec 1, 2025, 00:00

  • EE293 Cost-Savings Assessment of Fitusiran Prophylaxis in Minimizing Breakthrough Bleeding Treatment Expenses in the United Arab Emirates

    Dec 1, 2025, 00:00

  • EPH98 Examination of Attitudes Towards Vaccinations Among the Hungarian Population

    Dec 1, 2025, 00:00

  • EE579 Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia

    Dec 1, 2025, 00:00

  • HTA101 Cross-Agency Analysis of Six-Minute Walk Test (6MWT) Adoption in Muscular and Nonmuscular Neurological HTA Submissions: Assessing Surrogate Endpoints for Disease Progression

    Dec 1, 2025, 00:00

  • EPH208 Respiratory Syncytial Virus (RSV) Knowledge and Perceived RSV Risk Groups Amongst GP/PCPs and Specialists in APAC: A Cross-Sectional Knowledge Attitude and Practices Survey (RESVIKAP)

    Dec 1, 2025, 00:00

  • HPR222 Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-offs

    Dec 1, 2025, 00:00

  • EE99 Budget Impact Analysis of Tenecteplase vs. Alteplase for Adults With Acute Ischemic Stroke (AIS) in Greece

    Dec 1, 2025, 00:00

  • HPR189 Stakeholder Mapping and Policy Assessment of Rare Diseases in Southeast Asia

    Dec 1, 2025, 00:00

  • EE358 Economic Burden of COPD in Algeria: A Retrospective Analysis of Healthcare Resource Utilization and Costs

    Dec 1, 2025, 00:00

  • EPH173 Opportunity Gain in Resources as New Framework to Counterpart Burnout in Healthcare Systems

    Dec 1, 2025, 00:00

  • HTA300 Simulating PICOs to Predict Evidence Requirement Implications of the EU Joint Clinical Assessment: Learnings From 24 Case Studies

    Dec 1, 2025, 00:00

  • EE403 Economic Modeling in Ophthalmology: Reimagining Cost-Effectiveness Model Structures

    Dec 1, 2025, 00:00

  • EE350 Economic and Clinical Impact of Older Adult Vaccination With the Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico

    Dec 1, 2025, 00:00

  • HTA70 Challenges in Defining Target Populations: An Analysis of Orphan Drug Health Technology Assessments in Germany 2024

    Dec 1, 2025, 00:00

  • EE369 Economic Consequences of Disease-Related Malnutrition in Poland and the Potential Cost Savings From Nutritional Interventions: A Two-Step Modeling Study

    Dec 1, 2025, 00:00

  • HTA143 Examining the Relationship Between the NICE WTP Threshold and the Severity Modifier

    Dec 1, 2025, 00:00

  • EPH26 The Impact of Menopausal Hormone Therapy on Productivity and Health Care Utilization in Women: A Finnish Claims Database Study

    Dec 1, 2025, 00:00

  • HSD57 Hospital Community Integration: The Case of the Territorial Oncology Center at ASL 04 Teramo

    Dec 1, 2025, 00:00

  • PCR167 Outcome Measures Relevant for Assessing Health-Related Quality of Life and Utility in Primary Lateral Sclerosis (PLS)

    Dec 1, 2025, 00:00

  • EE330 Dihydropyrimidine Dehydrogenase (DPYD) Genetic Testing Before Fluoropyrimidine-Based Adjuvant Chemotherapy for Colorectal Cancer in Qatar: A Cost-Effective Approach

    Dec 1, 2025, 00:00

  • EE578 Microcosting Analysis of Oral, Subcutaneous, and Intravenous Second-line Multiple Sclerosis Treatments Administered at Home or in Hospital

    Dec 1, 2025, 00:00

  • MSR102 Exploring Artificial Intelligence's (AI's) Role in Literature Screening: A Comparative Analysis Paving the Way for More Efficient Evidence Synthesis

    Dec 1, 2025, 00:00

  • HTA72 Challenges in Predicting the Joint Clinical Assessment (JCA) Scope From a Stakeholder Perspective: A Case Study in Relapsed/Refractory Multiple Myeloma

    Dec 1, 2025, 00:00

  • SA87 Systematic Literature Review SLR Characterizing Humanistic Disease Burden and Unmet Needs in Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)

    Dec 1, 2025, 00:00

  • RWD66 Disease Severity at Advanced Therapy Initiation in Real-World Psoriasis Patients in the US

    Dec 1, 2025, 00:00

  • P3 Zoom In: Uncovering Clinical Nuance in Simplified Health Economic Model Structure Through Artificial Intelligence

    Dec 1, 2025, 00:00

  • RWD122 Medical Resource Utilizations and Economic Burden of Chemotherapy-Induced Anemia in Chinese Population: A Multicenter Retrospective Study

    Dec 1, 2025, 00:00

  • P29 Do Older People Always Prefer Avoiding Nursing Homes? Evidence in France From a Mixed-Methods Approach

    Dec 1, 2025, 00:00

  • EE618 Productivity and Cost-Effectiveness of Initiative for Decentralized Cancer Care in Region Uppsala, Sweden

    Dec 1, 2025, 00:00

  • RWD73 Economic Burden of Type 1 Diabetes Mellitus After Disease Onset: A Claims Data Analysis

    Dec 1, 2025, 00:00

  • CO95 Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials

    Dec 1, 2025, 00:00

  • EE575 Medicare Reimbursements Following Confirmatory MRI-Guided Biopsy vs. Systematic Biopsy Only in Low-Risk and Favorable Intermediate-Risk Prostate Cancer: A Real-World Cost Analysis Among Elderly Medicare Beneficiaries

    Dec 1, 2025, 00:00

  • EE727 The Socioeconomic Value of Adult Respiratory Immunization Programs in Spain: How Much Can We Gain From Expanding Prevention Efforts?

    Dec 1, 2025, 00:00

  • EE117 Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals

    Dec 1, 2025, 00:00

  • HTA16 A Systematic Literature Review of the Mitigation Strategies to Overcome the Risk for Confounding of Overall Survival in Trials With Crossover/Treatment Switching Evaluated in Health Technology Assessments of Treatments for Select Tumo ...

    Dec 1, 2025, 00:00

  • EPH161 Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective

    Dec 1, 2025, 00:00

  • EPH243 The Incidence and Survival of HPV-Positive and HPV-Negative Malignant Head and Neck Squamous Cell Carcinoma (HNSCC) in the United States: A Surveillance Epidemiology and End Results SEER 2000-2022 Database Analysis

    Dec 1, 2025, 00:00

  • PCR253 Understanding Patient Priorities in Psoriasis Treatment: A Review of Key Decision-Making Drivers

    Dec 1, 2025, 00:00

  • MSR36 Artificial Intelligence in Systematic Reviews: An Investigation Into the Impact of Eligible Studies Being Excluded by Artificial Intelligence

    Dec 1, 2025, 00:00

  • RWD49 Data Linkage in Practi A Living Systematic Review of Clinical Trials in the United States (US) Utilizing Linkage to Real-World Data

    Dec 1, 2025, 00:00

  • EE722 The Role of Unpaid Work in Measuring the Social Costs of Disease

    Dec 1, 2025, 00:00

  • EE447 Evaluating the Societal and Economic Impact of Immunotherapy for Melanoma Treatment in Bulgaria

    Dec 1, 2025, 00:00

  • EE288 Costs Associated With Kidney Transplant in Portugal

    Dec 1, 2025, 00:00

  • PCR6 A Methodological Review of WOMAC to EQ-5D Mapping Algorithms in Knee Osteoarthritis

    Dec 1, 2025, 00:00

  • MSR105 Exploring Perspectives on Adult Pneumococcal Vaccination: A Qualitative Preference Study of Healthcare Providers (HCPs) and Healthcare Consumers (HCCs) in the United Kingdom and Italy

    Dec 1, 2025, 00:00

  • CO97 Enterocutaneous Fistula (ECF) and Economic Burden Preliminary Data From a HEOR Model of a Laboratory (LAB) Experiment Plus Potential Cost Avoidance

    Dec 1, 2025, 00:00

  • EE81 Budget Impact Analysis of Dimethyl Fumarate for the Treatment of Relapsing/Remitting Multiple Sclerosis in Iraq

    Dec 1, 2025, 00:00

  • EE454 Experience of Single Dose IV Iron (Ferric Derisomaltose) Use in a Rural District General Medicine Ambulatory Unit and Overview of Its Economic and Sustainability Impact

    Dec 1, 2025, 00:00

  • SA100 Use of Innovative Methods in Long-Term Follow-up Observational Studies: An AI-Enabled Targeted Literature Review

    Dec 1, 2025, 00:00

  • EE411 Enhancing Operational Efficiency: Time and Cost Savings of a Minimally Invasive Vascular Closure Device in Germany

    Dec 1, 2025, 00:00

  • HSD5 AI-Enabled Extraction of eGFR and BRAF Testing Patterns in Advanced NSCLC: IMPACT-NSCLC, a Multicenter Real-World Study (2019-2024)

    Dec 1, 2025, 00:00

  • MSR200 The Natural History of Pancreatic Cancer and the Effectiveness of Screening a Model-Based Analysis

    Dec 1, 2025, 00:00

  • MT1 A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices

    Dec 1, 2025, 00:00

  • HPR204 The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals

    Dec 1, 2025, 00:00

  • CO45 Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • PCR163 Multiple Myeloma Caregiver Costs and Disabilities Data for Economic Modeling and HTA Submissions

    Dec 1, 2025, 00:00

  • EPH47 Colorectal Cancer Mortality Overview in Mexico 1998-2023

    Dec 1, 2025, 00:00

  • EPH36 Cardiovascular Event Rates and Mortality Among Secondary-Prevention Hypercholesterolemia Patients in Japan

    Dec 1, 2025, 00:00

  • RWD17 An Algorithm to Identify Immunocompromised Patients in French Claims Data for Rapid Preventive or Therapeutic Interventions

    Dec 1, 2025, 00:00

  • SA91 Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions

    Dec 1, 2025, 00:00

  • RWD30 Characteristics of Real-World Data Landscape in Spain: A Scoping Review

    Dec 1, 2025, 00:00

  • HTA211 Is NICE’s Proportionate Approach Achieving Its Objective: Analysis of Time to Access for Cost Comparison vs. Single Technology Appraisal

    Dec 1, 2025, 00:00

  • RWD164 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Previously Treated With First-Line (1L) Platinum-Based Chemotherapy (PBC)

    Dec 1, 2025, 00:00

  • CO121 External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)

    Dec 1, 2025, 00:00

  • PCR266 We Hear What You Are Saying: The Development and Design of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centered Outcomes Research Studies

    Dec 1, 2025, 00:00

  • EPH175 Patient-Relevant Benefits From Ixekizumab Treatment in Patients With Psoriasis: Data From the German National Psoriasis Registry PsoBest

    Dec 1, 2025, 00:00

  • HSD28 COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States

    Dec 1, 2025, 00:00

  • P33 Associations Between Undernutrition and Healthcare Utilization and Costs in Community-Dwelling Adults: A Longitudinal Observational Study

    Dec 1, 2025, 00:00

  • HTA77 Comparative Analysis of Economic Evaluation Frameworks for AI-Based Digital Health Technologies Across Four HTA Systems

    Dec 1, 2025, 00:00

  • EE208 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective

    Dec 1, 2025, 00:00

  • EE537 Impact of Mucus Plugs on the Health Economic Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Dec 1, 2025, 00:00

  • EE584 Modeling Early vs. Late Intervention Strategies: The Case of Dupilumab in Children With Severe Atopic Dermatitis

    Dec 1, 2025, 00:00

  • HSD51 From Admission to Discharge: Understanding the Transplant Patient Journey With German Statutory Health Insurance Claims Data

    Dec 1, 2025, 00:00

  • HPR93 Fair Pricing of Innovative Medicines From Definition to Application in CAR-T Cell Therapy

    Dec 1, 2025, 00:00

  • HTA198 Importance of Decisional Context in the Health Technology Assessment (HTA) of Ultra-Orphan Drugs

    Dec 1, 2025, 00:00

  • SA7 Adjusting to Nonoverlapping Variables in the Unanchored Matching-Adjusted Indirect Comparisons of Survival Outcomes: Application of Monte Carlo Simulations

    Dec 1, 2025, 00:00

  • EE471 Financing Sustainable Public Health: Design of a Herpes Zoster Prevention Bond to Fund Vaccination

    Dec 1, 2025, 00:00

  • HPR9 A Review of the UK's International Recognition Procedure and Its Role in Expediting Access to Innovative Treatments

    Dec 1, 2025, 00:00

  • PCR63 Development of Two Versions of a Patient-Preference Questionnaire for Evaluating Potential HIV Cure-Related and Other HIV Interventions

    Dec 1, 2025, 00:00

  • PCR143 Investigating the Importance of EQ-5D Domains and Two Bolt-on Items: How Do the Preferences of People With Acute Leukemia Differ From the General Population?

    Dec 1, 2025, 00:00

  • HTA153 From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe

    Dec 1, 2025, 00:00

  • EE509 Healthcare Resource Utilization (HCRU) and Associated Costs in Patients With Advanced Merkel Cell Carcinoma (aMCC) in Germany: Analysis From the MCC TRIM Registry Study

    Dec 1, 2025, 00:00

  • PCR35 Can We Quantify the Financial Impact of Patient-Reported Outcomes on the Value of Oncology Products?

    Dec 1, 2025, 00:00

  • MT6 Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework

    Dec 1, 2025, 00:00

  • HTA118 Early Health Technology Assessment and Cost-Effectiveness of the National Cardiovascular Disease Prevention Program in Greece

    Dec 1, 2025, 00:00

  • PCR42 Characterizing the UK Population Living With Von Willebrand Disease: Foundational Data for Health Economics and Outcomes Research

    Dec 1, 2025, 00:00

  • RWD171 Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection

    Dec 1, 2025, 00:00

  • EPH228 The Association Between Schizophrenia and Cardiovascular Diseases: A Retrospective Cohort Study in German Primary Care

    Dec 1, 2025, 00:00

  • MT14 Digital Therapeutics in Europe: A Structured Review of Reimbursement and Access Pathways

    Dec 1, 2025, 00:00

  • CO5 A Systematic Review and Network Meta Analysis of Pharmacologic Disease-Modifying Therapies for Early Alzheimer's Disease

    Dec 1, 2025, 00:00

  • HPR161 Physicians’ Knowledge, Attitude, and Practice Regarding Medical Liability: A Study in Saudi Arabia

    Dec 1, 2025, 00:00

  • EE326 Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes

    Dec 1, 2025, 00:00

  • EE243 Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden

    Dec 1, 2025, 00:00

  • EPH265 Tropical Virus in Fran Dengue Cases on the Rise

    Dec 1, 2025, 00:00

  • EE519 Hereditary Transthyretin Amyloidosis (ATTRv) Below the Age of 70 Healthcare Resource Utilization and Mortality

    Dec 1, 2025, 00:00

  • PCR214 Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries

    Dec 1, 2025, 00:00

  • PCR3 A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Among Adolescents Aged 10-18 in China

    Dec 1, 2025, 00:00

  • RWD102 Improving Identification of Patients With Rare Diseases Through Indirect Linkage Between French Medico-Administrative Claims Database (SNDS) and National Rare Disease Registry (BNDMR) in Fran A Dual-Population Study

    Dec 1, 2025, 00:00

  • HPR64 Drivers and Barriers of Biosimilar Uptake in APAC

    Dec 1, 2025, 00:00

  • EE325 Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA

    Dec 1, 2025, 00:00

  • RWD105 Inducing Labor in Denmark: A Descriptive Study

    Dec 1, 2025, 00:00

  • CO4 A Systematic Review (SR) and Network Meta-Analysis (NMA) of Cystic Fibrosis Transmembrane Conductance Receptor (CFTR) Modulator Therapies and Established Clinical Management (ECM) Using Percent Predicted Forced Expiratory Volume in One ...

    Dec 1, 2025, 00:00

  • CO79 Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology

    Dec 1, 2025, 00:00

  • HTA175 Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective

    Dec 1, 2025, 00:00

  • HTA19 Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child

    Dec 1, 2025, 00:00

  • OP23 Streamlining Cancer Treatment Pathways: Organizational Responses to Rising Chemotherapy Volumes

    Dec 1, 2025, 00:00

  • PCR216 Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)

    Dec 1, 2025, 00:00

  • HSD18 Burden of In-Clinic and At-Home Administration of Injectable Biologics for Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Interim Results From a Time and Motion Study

    Dec 1, 2025, 00:00

  • EPH45 Clinical Profile of Asthma and Its Geographical Variability in Southern Spain

    Dec 1, 2025, 00:00

  • HTA124 Enhancing Patient Involvement in European Health Technology Assessment (HTA): From Inconsistent National Practices to Systematic Engagement in Joint Clinical Assessments

    Dec 1, 2025, 00:00

  • EE705 The Economic Impact of Time-to-Target-Temperature of Different Surface Cooling Technologies for Temperature Management in Critically Ill Patients: A Systematic Review, Analysis, and Model

    Dec 1, 2025, 00:00

  • HSD75 Modeling the Anticipated Organizational Impact on Health Service Provision of the Introduction of Tirbanibulin for the Topical Treatment of Actinic Keratosis in Fran EPIKA Study

    Dec 1, 2025, 00:00

  • MT15 Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review

    Dec 1, 2025, 00:00

  • EE590 Modeling Treatment-Free Remission Outcomes for Asciminib in Newly Diagnosed Chronic Myeloid Leukemia: Assumptions, Methodology, and Projections

    Dec 1, 2025, 00:00

  • PCR77 Equivalence of Measurement Properties of the Dermatology Life Quality Index (DLQI) Across 13 European Countries

    Dec 1, 2025, 00:00

  • EE29 A Real-World Study of Healthcare Resource Utilization (HCRU) and Associated Healthcare Costs for Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) in Taiwan

    Dec 1, 2025, 00:00

  • EE220 Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in Spain

    Dec 1, 2025, 00:00

  • MSR179 Reducing the Rare Disease Diagnostic Odyssey: Identifying Potential Pulmonary Arterial Hypertension Patients Using the Problem List of Diagnosed Patients

    Dec 1, 2025, 00:00

  • MSR60 Comparison EQ-5D-Y-3L Responses Between Child Self-Reports and Caregiver Proxy Reports

    Dec 1, 2025, 00:00

  • EE365 Economic Burden of Schizophrenia: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • CO206 Real-World Observational Study of PAP Therapy Outcomes in Czech Patients With Sleep Apnea

    Dec 1, 2025, 00:00

  • CO205 Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review

    Dec 1, 2025, 00:00

  • MSR30 Applying G-methods to Account for Treatment Switching in Postmarketing Effectiveness Evaluation: A Case Study of GLP-1 Receptor Agonists for Diabetic Kidney Disease

    Dec 1, 2025, 00:00

  • EE299 Cost-Utility Analysis of AI-Assisted Ultrasound for Breast Cancer Detection in Taiwan

    Dec 1, 2025, 00:00

  • RWD132 Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons

    Dec 1, 2025, 00:00

  • HSD83 Patterns Of Adoption And Diffusion Of Biological Therapies In Inflammatory Bowel Disease: Patient-Centric Insights From Israel

    Dec 1, 2025, 00:00

  • CO155 Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version

    Dec 1, 2025, 00:00

  • RWD101 Improving Data Quality in Oncology Electronic Health Record (EHR)-Derived Databases for Research and Regulatory Decision Making

    Dec 1, 2025, 00:00

  • EPH244 The Incidence, Mortality, and Survival of Breast Cancer per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis

    Dec 1, 2025, 00:00

  • EPH254 The Role of Body Fat in the Regulation of Male Fertility

    Dec 1, 2025, 00:00

  • EE203 Cost-Effectiveness Analysis of Health2Sync Application With Patient Management Program Compared to Traditional Care for Patients With Type 2 Diabetes Mellitus in Taiwan

    Dec 1, 2025, 00:00

  • PCR90 Exploring Beyond the Gut: A Qualitative Study of Extraintestinal Symptoms in Ulcerative Colitis and Crohn's Disease

    Dec 1, 2025, 00:00

  • HTA328 The Rise of Optimization in NICE Guidan A Two-Decade Review With a Focus on Prevention

    Dec 1, 2025, 00:00

  • HTA334 The Uptake of R in NICE HTA: Insights From Technology Assessment Groups

    Dec 1, 2025, 00:00

  • EE678 Systematic Review of Decision-Analytic Models Estimating the Economic Impact of Prescription Opioid Use and Associated Adverse Events

    Dec 1, 2025, 00:00

  • MSR28 Anchors Away: Navigating Unanchored Indirect Comparisons With Multilevel Unanchored Meta-Regression (ML-UMR)

    Dec 1, 2025, 00:00

  • MT8 Changes in Medical Technology Availability in Europe Between 2000 and 2020

    Dec 1, 2025, 00:00

  • MSR32 Applying the Delphi Method: A Scoping Review in Healthcare Decision Making and HEOR

    Dec 1, 2025, 00:00

  • EE670 Spinal Muscular Atrophy Treatments in Fran What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations

    Dec 1, 2025, 00:00

  • RWD26 Burden of Duchenne Muscular Dystrophy in Italy: A Multicenter Cost of Illness Study

    Dec 1, 2025, 00:00

  • PCR188 Potential Impacts of Participating in an HIV Cure-Related Trial With an Analytical Treatment Interruption on Partners: Qualitative Research Findings

    Dec 1, 2025, 00:00

  • SA76 Pragmatic Advice to Improve Assessment Schedule of Preference-Based Measures of Health to Estimate Utilities in Clinical Trials

    Dec 1, 2025, 00:00

  • CO129 Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study

    Dec 1, 2025, 00:00

  • HPR151 Optimizing Healthcare Systems in the MENA Region: Insights From Tailored Reimbursement for Innovative and Generic Essential Remedies (TRIGER) Meetings in Saudi Arabia and Algeria

    Dec 1, 2025, 00:00

  • PT23 Optimizing Market Access in Europe: A Comparative Analysis of Submission Templates from the EU JCA and National HTA Bodies (HAS, G-BA, ZIN, DMC)

    Dec 1, 2025, 00:00

  • MSR221 What Is the Value of Large Language Models for Improving Extraction and Interpretation of Efficiency Data From French Commission Dévaluation Économique et de Santé Publique (CEESP): Decisions on Breast Cancer Medications?

    Dec 1, 2025, 00:00

  • EE87 Budget Impact Analysis of Hyaluronic Acid Viscosupplementation for Knee Osteoarthritis in Colombia

    Dec 1, 2025, 00:00

  • CO165 Modeling Intelligence Quotient (IQ) Changes Relative to Blood Phe Levels in Individuals With Phenylketonuria (PKU) Treated With Sepiapterin and Sapropterin Dihydrochloride

    Dec 1, 2025, 00:00

  • HPR3 A Comparative Analysis of Early Access Pathways in Italy and Fran Law 64896 vs. the French AAP

    Dec 1, 2025, 00:00

  • MSR9 A Retrieval-Augmented Generation (RAG)-Based Framework to Automate Report Writing for Systematic Literature Reviews (SLRs) in Evidence Synthesis

    Dec 1, 2025, 00:00

  • MSR157 Optimized Piecewise Exponential Modeling Using Dynamic Programming: An Illustration From Treatment-Naïve Advanced Melanoma

    Dec 1, 2025, 00:00

  • EE155 Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal

    Dec 1, 2025, 00:00

  • PT3 Radiographic Progression-Free Survival (rPFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Meta-Analysis and Surrogate Threshold Effect

    Dec 1, 2025, 00:00

  • EE718 The Ongoing Challenge of Clostridioides Difficile Infection in Austria: Economic Evaluation of Two Recommended Treatment Pathways

    Dec 1, 2025, 00:00

  • PCR117 Health-Related Quality of Life in Patients Living With Osteosarcoma in Europe: A Systematic Review

    Dec 1, 2025, 00:00

  • EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)

    Dec 1, 2025, 00:00

  • EE606 Patient Blood Management With Intravenous Iron Is Economically Advantageous Compared to Usual Care in German Hospitals

    Dec 1, 2025, 00:00

  • CO98 Epidemiological Study of Pulmonary Hypertension in Patients With Interstitial Lung Diseases (PH-ILD) in Gree A Retrospective Multicenter Study

    Dec 1, 2025, 00:00

  • EE660 Societal and Economic Impact of NOAC Therapy for Deep Vein Thrombosis and Pulmonary Embolism in Bulgaria

    Dec 1, 2025, 00:00

  • EPH137 Impact of the Decline in the Number of Community Dermatologists in France on Treatment of Actinic Keratosis (EPIKA Study)

    Dec 1, 2025, 00:00

  • CO90 Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

    Dec 1, 2025, 00:00

  • RWD24 Association of Recurrences With Healthcare Resource Utilization in High-Risk Non-Muscle Invasive Bladder Cancer Patients Across Europe: A Real-World Survey

    Dec 1, 2025, 00:00

  • HTA348 US PIE and AMCP Dossiers: Payer Preferences Best Practice and a Comparison With Global Evidence Dossiers

    Dec 1, 2025, 00:00

  • PCR119 Health-Related Quality of Life in Patients With Mild Cognitive Impairment and Dementia and Their Caregivers in Thailand: A Cross-Sectional Study

    Dec 1, 2025, 00:00

  • EE260 Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile

    Dec 1, 2025, 00:00

  • HPR125 Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024

    Dec 1, 2025, 00:00

  • MSR73 Development of Cardiovascular Risk Equations: Integrating Clinical Expertise With Data From the SELECT Trial

    Dec 1, 2025, 00:00

  • HTA46 Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)

    Dec 1, 2025, 00:00

  • HTA174 Health Technology Assessment Landscape for Medical Devices in Europe

    Dec 1, 2025, 00:00

  • HTA9 A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy

    Dec 1, 2025, 00:00

  • SA52 Impact of Different Thresholds of Increasing or Decreasing Body Mass Index on Noncommunicable Diseases Through a Discrete Event Simulation Model

    Dec 1, 2025, 00:00

  • EE174 Cost Implications of Declining MMR Coverage in England: Modeling NHS Burden and the Value of Catch-Up Vaccination

    Dec 1, 2025, 00:00

  • P60 The Social Impact of Health (SIoH) Framework: Capturing How Health-Driven Productivity Shapes National Development

    Dec 1, 2025, 00:00

  • PCR141 Integrating PROMs Into Real-World Ophthalmology Practi A Pilot Project on Neovascular AMD

    Dec 1, 2025, 00:00

  • EPH261 Trends in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prescribing in England: A Data Analysis Using NHS Prescription Episodes Statistics (PES)

    Dec 1, 2025, 00:00

  • HTA225 LLM Engineering in HEOR: Approaches to Improving Accuracy in Clinical Data Extraction

    Dec 1, 2025, 00:00

  • EPH78 Epidemiology and Demographic Characteristics of Phenylketonuria in Brazil: A Real-World Data Study (2019-2024)

    Dec 1, 2025, 00:00

  • CO159 Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0

    Dec 1, 2025, 00:00

  • EE570 Malnutrition-Related Healthcare Costs in Hospitalized IBD Patients: A Nationwide Real-World Data Analysis in Italy

    Dec 1, 2025, 00:00

  • EE751 What Are the Biggest Value Drivers? A Comparison of the Relative Impacts of Six Novel Value Elements on Value Estimates Across Twelve Treatments Through Generalized Cost-Effectiveness Analyses

    Dec 1, 2025, 00:00

  • HTA277 Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?

    Dec 1, 2025, 00:00

  • EE221 Cost-Effectiveness Analysis of the Prostate Health Index (PHI) Test After a Prostate-Specific Antigen (PSA) Test in UK

    Dec 1, 2025, 00:00

  • P64 Patient Engagement in Economic Evaluations of Cancer Care: Mapping the Landscape and Advancing Practice

    Dec 1, 2025, 00:00

  • EE702 The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • HPR203 The Impact of the COVID-19 Pandemic on the Performance of the Hospital Care System in Romania as Measured Using the Diagnosis-Related Groups (DRGs) Financing Technique

    Dec 1, 2025, 00:00

  • HPR170 Real-World Data for External Controls: Insights From EMA Regulatory Submissions

    Dec 1, 2025, 00:00

  • MT26 HTA Requirements for Medical Technologies in Germany

    Dec 1, 2025, 00:00

  • HSD29 CREST Physician Experience Survey: Evaluating the Impact of Time and Effort of Treatment Administration in Non-Muscle Invasive Bladder Cancer (NMIBC)

    Dec 1, 2025, 00:00

  • EE612 Potential Public Health Benefits of Recombinant Influenza Vaccines in Older Adults in England and Wales

    Dec 1, 2025, 00:00

  • CO194 Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Illness Among High-Risk Adults Aged 18-59 Years in Germany

    Dec 1, 2025, 00:00

  • SA77 Premium Relief Through Prevention: Actuarial Valuation of Herpes Zoster Vaccination

    Dec 1, 2025, 00:00

  • HTA130 Evaluating Clinical Similarity: A Systematic Review of Methods Used Within National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) When Relying on Statistically Nonsignificant Differences From Indi ...

    Dec 1, 2025, 00:00

  • EPH270 Unmet Need and the Public Health Grant: A Data-Driven Tool for Local Authority Spending Decisions

    Dec 1, 2025, 00:00

  • HSD23 Characteristics of DNAR Orders Among Non-Critically Ill Extremely Elderly Patients Admitted to a University Hospital in Japan

    Dec 1, 2025, 00:00

  • PCR250 Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in China: Insights From CHOICE-CSU 2 Study

    Dec 1, 2025, 00:00

  • EE120 Can Intravitreal Aflibercept 8 mg Result in Decreased Treatment Burden and Treatment Costs in European Patients With Age-Related Macular Degeneration? Early Evidence From Clinical Practice

    Dec 1, 2025, 00:00

  • CO51 Clinical Utility of Multiplex Point of Care (PCR) Compared to Antigen Testing for Influenza-Like Illness in the Hospital Emergency Department

    Dec 1, 2025, 00:00

  • CO140 Impact of Pharmacotherapy Adherence on the Reduction of Major Adverse Cardiovascular Events (MACE) Among Atherosclerotic Cardiovascular Disease (ASCVD) Patients

    Dec 1, 2025, 00:00

  • EE698 The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia

    Dec 1, 2025, 00:00

  • EE425 Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma

    Dec 1, 2025, 00:00

  • Disclosure Information

    Dec 1, 2025, 00:00

  • EPH197 Public Health and Economic Impact of RSVpreF Vaccination Among Older Adults in Latin America and the Caribbean

    Dec 1, 2025, 00:00

  • EE629 Quantifying the Impact of Inconsistencies in Economic Modeling Assumptions: A Case Study in Metastatic Colorectal Cancer

    Dec 1, 2025, 00:00

  • EE620 Projected Public Health Impact of Synchronized COVID-19 and Influenza Vaccination With a Combination Vaccine in US Older Adults

    Dec 1, 2025, 00:00

  • MSR118 Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies

    Dec 1, 2025, 00:00

  • CO128 Health Technology Assessment, Reimbursement, and Funding Landscape Challenges for Oncology Companion Diagnostics in Europe and Canada

    Dec 1, 2025, 00:00

  • RWD110 Integrating Prospective and Retrospective Real-World Data to Construct External Comparator Arms: Novel Methods and Design Considerations

    Dec 1, 2025, 00:00

  • EE420 Estimating Healthcare Resource Use Associated With the Treatment of Phenylketonuria in the United States

    Dec 1, 2025, 00:00

  • MSR108 Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis

    Dec 1, 2025, 00:00

  • EPH69 Effectiveness of HPV Vaccination Across Europe: A Comparative Analysis

    Dec 1, 2025, 00:00

  • HTA342 Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals

    Dec 1, 2025, 00:00

  • EE324 Developing the Next Generation of Therapeutics: The Role of Early Model-Based Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • HTA344 Ukraine’s First Horizon Scanning Pilot: Lessons for HTA Implementation

    Dec 1, 2025, 00:00

  • EE412 Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy

    Dec 1, 2025, 00:00

  • MSR151 Modeling the Future Clinical and Environmental Burden of Chronic Kidney Disease in Ghana and Uganda Between 2025 and 2030

    Dec 1, 2025, 00:00

  • EE47 An Economic Evaluation to Inform the Use of Enhanced Influenza Vaccines for Those Aged 65 Years and Older in the Seasonal Influenza Vaccination Program in Ireland

    Dec 1, 2025, 00:00

  • EE346 Early Diagnosis and Treatment Optimization in Heart Failure Through NT-proBNP Testing in Primary and Specialist Care

    Dec 1, 2025, 00:00

  • EE122 CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling

    Dec 1, 2025, 00:00

  • CO253 Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey

    Dec 1, 2025, 00:00

  • RWD47 DARAH Project: Deploying a Datashield Federated Network in Real-World Healthcare Environments

    Dec 1, 2025, 00:00

  • MSR59 Comparing Key European HTA Body Methodological Standards for Systematic Reviews of Economic and Utility Evidence

    Dec 1, 2025, 00:00

  • EPH172 Objective Real-World Caregiver Costs and Lost Time for Absences and Family Medical Leaves in the United States for Employees Whose Spouses Have Dementia and/or Alzheimer’s Disease and Patient Direct Costs

    Dec 1, 2025, 00:00

  • EPH5 A Real-World Study on Hospital and Economic Burden of Dengue Fever in French Overseas Territories

    Dec 1, 2025, 00:00

  • CO174 Overall Survival With Second-Generation Androgen-Receptor Signaling Inhibitors in Patients With Metastatic Castration Resistant Prostate Cancer: An Umbrella Review

    Dec 1, 2025, 00:00

  • PCR203 Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study

    Dec 1, 2025, 00:00

  • HPR134 Maintaining Orphan Drug Status at the Time of Drug Approval in European Economic Area (EEA): European Union (EU) Plus Iceland and Norway From 2015 to 2025

    Dec 1, 2025, 00:00

  • PCR198 Psychometric Validation Of The North Star Assessment For Limb-Girdle Type Muscular Dystrophies (NSAD) In Limb-Girdle Muscular Dystrophy Sarcoglycanopathies (LGMD 2C/2D/2E) Using Baseline JOURNEY Data

    Dec 1, 2025, 00:00

  • HTA137 Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals

    Dec 1, 2025, 00:00

  • EE736 Treatment Patterns and Healthcare Resource Utilization in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in England: A Retrospective, Observational Cohort Study

    Dec 1, 2025, 00:00

  • HPR194 The Clawbacks Paradox: When Abusing a Simple Approach Has the Most Complicated and Problematic Consequences for Patients and Healthcare Systems

    Dec 1, 2025, 00:00

  • RWD163 Real-World Study of Breast Cancer Epidemiology and Treatment Patterns: A Pilot Study to Assess EHR-Derived Data in the United Kingdom

    Dec 1, 2025, 00:00

  • EE662 Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan

    Dec 1, 2025, 00:00

  • HTA301 Stakeholder Involvement in the Health Technology Assessment Process in Ukraine

    Dec 1, 2025, 00:00

  • P5 The Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the US: A Total System Value Evidence Framework

    Dec 1, 2025, 00:00

  • EE261 Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain

    Dec 1, 2025, 00:00

  • EPH184 Prediabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization

    Dec 1, 2025, 00:00

  • EE182 Cost of Treatment of Metastatic Non-Small Lung Cancer in Sweden, 2011-2023

    Dec 1, 2025, 00:00

  • EE308 Cost-Utility Analysis of Standard-Dose vs. High-Dose Influenza Vaccination in Adults Aged ≥ 65 Years in Italy

    Dec 1, 2025, 00:00

  • SA59 Laboratory Testing Patterns in Patients With Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Country Electronic Health Record Study From the UK, Germany, and Japan

    Dec 1, 2025, 00:00

  • PCR80 Evaluating Migration Errors in COA: Development and Validation of the IQVIA Migration Error Severity Scale (I-MESS)

    Dec 1, 2025, 00:00

  • CO17 Assessment of Newly Developed Medication Adherence Tool in Rural Community Pharmacies

    Dec 1, 2025, 00:00

  • EE734 Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder

    Dec 1, 2025, 00:00

  • EE216 Cost-Effectiveness Analysis of Pharmacogenetic Testing to Guide Treatment for Children With Asthma

    Dec 1, 2025, 00:00

  • RWD142 Real-World Healthcare Resource Utilization and Costs Associated With Malignant Brain Tumors in the Brazilian Private Market

    Dec 1, 2025, 00:00

  • EE613 Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population

    Dec 1, 2025, 00:00

  • HPR196 The Development of the Private Healthcare Sector in Romania Between 2005 and 2023

    Dec 1, 2025, 00:00

  • RWD28 Characteristics of Patients Treated With Biologic Agents for Moderate-to-Severe Atopic Dermatitis in Poland

    Dec 1, 2025, 00:00

  • CO10 Analysis of Pooled Real-World Utilization and Outcomes Data of rVIII-Single Chain Compared With Standard and Extended Half-Life FVIII Products for Prophylaxis of Hemophilia A in France, Germany, and Italy

    Dec 1, 2025, 00:00

  • PCR27 Association Between Subjective Sleep Quality and Quality of Life (QoL) Linked With Claims Data in the DeSC Healthcare Database in Japan

    Dec 1, 2025, 00:00

  • EPH176 Persistence With Antidementia Therapy in Germany: A Retrospective Cohort Study of 212,850 Patients

    Dec 1, 2025, 00:00

  • Medicare Drug Price Negotiation Under the Inflation Reduction Act: Ensuring the Continuity of Critical Real-World Pharmaceutical Studies

    Dec 1, 2025, 00:00

  • HPR127 International Reference Pricing (IRP) Analysis for Generic Medicines in Türkiye in 2024

    Dec 1, 2025, 00:00

  • EPH30 Budget Impact of an Organized Colorectal Cancer Screening in High-Risk Populations in France

    Dec 1, 2025, 00:00

  • EE465 Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States

    Dec 1, 2025, 00:00

  • P42 A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative

    Dec 1, 2025, 00:00

  • EE581 Mobile Diagnostic Services for Stationary Care in Germany: An Economic Evaluation Model for the DIKOM Project (01NVF21101)

    Dec 1, 2025, 00:00

  • HPR195 The Czech Republic’s Dedicated Orphan Drug Reimbursement Mechanism 2022-2025: Improvements in Access

    Dec 1, 2025, 00:00

  • EE145 Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion

    Dec 1, 2025, 00:00

  • PCR55 Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria

    Dec 1, 2025, 00:00

  • CO118 Exploring Synergistic ADC-ICI Combinations in Breast Cancer: Clinical Insights From a Scoping Review

    Dec 1, 2025, 00:00

  • MSR109 Fitting Flexible Survival Models to Landmark Survival Estimates in R

    Dec 1, 2025, 00:00

  • EE60 Assessing the Cost-Effectiveness of Subcutaneous Semaglutide 2.4 mg in the Management of Individuals With Obesity and Prediabetes in England

    Dec 1, 2025, 00:00

  • EE546 Improved Outcomes and Cost Savings With the New-Generation Balloon-Expandable Covered Stent in Aortoiliac Occlusive Disease: Preliminary Results Overview From an Italian Perspective

    Dec 1, 2025, 00:00

  • RWD97 Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis

    Dec 1, 2025, 00:00

  • SA74 Patient Characteristics and Treatment Comparison Among Patients With Chronic Obstructive Pulmonary Disease: Real-World Evidence From Sweden

    Dec 1, 2025, 00:00

  • CO69 Delphi Panel for Standardizing Outcome Measures in Radical Prostatectomy Surgical Care Pathway

    Dec 1, 2025, 00:00

  • RWD27 Challenges and Opportunities in Using Real-World Data for Healthcare in the Middle East and North Africa Region: A Systematic Scoping Review

    Dec 1, 2025, 00:00

  • MSR213 Use of Multilevel Network Meta Regression (ML-NMR) Model in RET Mutation-Positive Medullary Thyroid Cancer (MTC)

    Dec 1, 2025, 00:00

  • MSR170 Predicting PICOs Through Machine-Learning–Powered Information Compression and Statistical Ranking

    Dec 1, 2025, 00:00

  • EE524 Humanistic and Economic Burden of Primary Biliary Cholangitis: A Systematic Review of Health-Related Quality of Life Healthcare Resource Utilization and Associated Cost

    Dec 1, 2025, 00:00

  • CO53 Comparative Effectiveness of Alectinib vs. Crizotinib as First-Line Therapy in ALK-Positive Non-Small Cell Lung Cancer: A Real-World Quasi-Experimental Study

    Dec 1, 2025, 00:00

  • EE374 Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan

    Dec 1, 2025, 00:00

  • EE298 Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction

    Dec 1, 2025, 00:00

  • EPH7 A Real-World Survey of Health Inequalities as Drivers for Burden on Male Hemophilia Patients in the US, EU5, and Asia

    Dec 1, 2025, 00:00

  • RWD96 Health-Related Quality of Life in Adults With Dry Eye Disease in Fran Insights From a Multicenter Observational Study

    Dec 1, 2025, 00:00

  • SA62 Leveraging Real-World Data to Conduct Noninterventional Studies in Rare Disease Populations: Lessons in Scalability and Data Access From Three Observational Studies

    Dec 1, 2025, 00:00

  • HTA140 Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis

    Dec 1, 2025, 00:00

  • PCR54 Cross-Country Comparison of Cancer-Related Health Preferences Using the EORTC QLU C10D: Evidence Supporting Standardized Value Sets

    Dec 1, 2025, 00:00

  • HSD31 Definitive Staging and Perioperative Treatment for Resectable Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC): A UK Perspective

    Dec 1, 2025, 00:00

  • HSD66 Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review

    Dec 1, 2025, 00:00

  • PT28 Cross-Validation of the Glycated Hemoglobin HbA1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs

    Dec 1, 2025, 00:00

  • EE80 Budget Impact Analysis of 68-Ga-PSMA-11 PET CT Imaging Followed by 177Lu-PSMA-617 Therapy in Metastatic Castrate-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • EE142 Comparing the Economic Burden in Patients With vs. Without Ehlers-Danlos Syndrome (EDS) Using a Large US Electronic Health Records Database

    Dec 1, 2025, 00:00

  • RWD58 Detection of a Novel Safety Signal for Atorvastatin Potential Association With Hilar Lymphadenopathy Using FAERS Disproportionality Analysis and Molecular Docking

    Dec 1, 2025, 00:00

  • RWD131 Oracle Real-World Data: Analysis of the Characteristics and Representativeness of Oracle's Linked EHR-Claims Database

    Dec 1, 2025, 00:00

  • HTA35 Applicability of the STEDI Value Framework to Vaccines in Health Technology Assessment: Opportunities and Considerations

    Dec 1, 2025, 00:00

  • HTA156 From Pilot to Platform: Expanding Generative AI Coauthoring Across Global Value Dossier (GVD) Sections With Proven Quality and Validation

    Dec 1, 2025, 00:00

  • SA106 Work Productivity Loss Among Caregivers of Pediatric Patients With COVID-19 OR Influenza/Influenza-Like Illness: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • HTA144 Exploring Evidence Gaps in National Institute for Health and Care Excellence Early Value Assessments

    Dec 1, 2025, 00:00

  • CO141 Impact of Prenatal Exposure to Antidepressants on Adverse Birth and Pregnancy Outcomes: A Propensity-Scored Matched Retrospective Cohort Study Using a Large Electronic Medical Record Database 2012-2021

    Dec 1, 2025, 00:00

  • HTA15 A Review of Utility Data Used in Health Technology Assessments From the Perspective of a Health Technology Assessment Body

    Dec 1, 2025, 00:00

  • EE441 Evaluating the Economic Burden of Polycythemia Vera Across the Disease Continuum: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • HPR207 The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance

    Dec 1, 2025, 00:00

  • PT34 A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Gree Proposal for a Medicines Innovation Fund

    Dec 1, 2025, 00:00

  • EE20 A Method to Estimate Causally Related Cost Savings of a Preventive Intervention: An Analysis Using the Wellness-Star∗ Database

    Dec 1, 2025, 00:00

  • CO37 Cardiovascular Effects of Semaglutide in Patients With Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review

    Dec 1, 2025, 00:00

  • EE491 Health Economic Evaluation Model for Pancreatic Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)

    Dec 1, 2025, 00:00

  • EPH104 Exploring Factors Associated With Online Food Delivery Behavior Among Young Adults

    Dec 1, 2025, 00:00

  • PCR124 Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy

    Dec 1, 2025, 00:00

  • Award Winners

    Dec 1, 2025, 00:00

  • EPH211 Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy Patients in the Brazilian Public Health System: A Real-World Study

    Dec 1, 2025, 00:00

  • OP20 Qualitative Insights Into Artificial Intelligence (AI) and Virtual Reality (VR) Training for Value Communication: Comparing Innovative Technologies With Traditional Methods in Pharma

    Dec 1, 2025, 00:00

  • EE218 Cost-Effectiveness Analysis of RefluxStop for Treatment of Chronic Gastro-esophageal Reflux Disease: A US Medicare Perspective

    Dec 1, 2025, 00:00

  • EE596 Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal

    Dec 1, 2025, 00:00

  • EE649 Requirements for Payer Recognition of Disease-Modifying Effect in New Drug Launches

    Dec 1, 2025, 00:00

  • HTA85 Competing Beyond the First Mover: How Late to Market Analogues Navigate Pricing and Access in Major Global Markets

    Dec 1, 2025, 00:00

  • PCR38 Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey

    Dec 1, 2025, 00:00

  • HTA324 The Next Frontier in HTA Reviewing the Integration of Artificial Intelligence and Discrete Event Simulation for Resource Modeling

    Dec 1, 2025, 00:00

  • HTA139 Evolution of Acceptance of Evidence and PMA Outcomes by HTA Authorities for ATMPs in the EU4 and the UK 2017-2025

    Dec 1, 2025, 00:00

  • HPR175 Resilient Pharmaceutical Supply Chains in Times of Crisis: A Comparative Analysis of Australia, France, Italy, Spain, and UK

    Dec 1, 2025, 00:00

  • HSD2 A Comprehensive Approach Including Mailed FITs and Nurse Navigation for Colorectal Cancer Screening

    Dec 1, 2025, 00:00

  • PCR25 Assessment of Dermatology Life Quality Index Relevant (DLQI-R) in Psoriasis: A Practical Tool for Measuring Quality of Life in Elderly Populations

    Dec 1, 2025, 00:00

  • EE681 Systems Simulation Methods for the Economic Evaluation of Non-Medicines and Nonsurgical Interventions: A Systematic Literature Review of Quality and Methods for Reproducing Complexity in Health and Health Behaviors

    Dec 1, 2025, 00:00

  • EPH120 Healthcare Pathway of a Large Cohort of Patients With Chronic Obstructive Pulmonary Disease During the Last Year of Life

    Dec 1, 2025, 00:00

  • HPR230 Unlocking Access: Overcoming Barriers and Harnessing Enablers for Innovative Payment Models for Pharmaceutical Innovation in Europe

    Dec 1, 2025, 00:00

  • HSD71 Mapping the Burden of Seizure Emergencies in Spain: A Systematic Literature Review

    Dec 1, 2025, 00:00

  • HTA341 Treatment Effect Extrapolation Assumptions in NICE Highly Specialized Technology Appraisals

    Dec 1, 2025, 00:00

  • MSR162 PACE in Scotland: Utilizing Machine Learning to Assess the Importance of Patient and Clinician Engagement in HTAs in SMC

    Dec 1, 2025, 00:00

  • SA29 Design, Implementation, Data Analysis on the Time-Motions Studies: A Targeted Literature Review

    Dec 1, 2025, 00:00

  • HSD21 Care Pathways Before and After Initial Diagnosis and Geographical Disparities Among Patients With Obstructive Hypertrophic Cardiomyopathy in Fran A Retrospective Claims Analysis

    Dec 1, 2025, 00:00

  • HPR98 Fragmentation in Access Pathways: A Review of HTA and Decision-Making Processes for Medicines in Finland

    Dec 1, 2025, 00:00

  • MSR219 Variations in Mortality Across Clinical Trials: A Review of Statistical Methods for Adjusting for the Effect of the COVID-19 Pandemic

    Dec 1, 2025, 00:00

  • HTA138 Evidence Strategy Starts Early: Integrating HTA Needs Through PICO Simulation in Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2025, 00:00

  • HSD24 Clinical Characteristics Among Patients Screening for Hepatitis C Virus (HCV) and HCV Positivity Rates, 2020-2024: Analysis of US Real-World Data

    Dec 1, 2025, 00:00

  • HSD106 The DM77 and Rare Diseases: Analysis of Regional Legislation in Italy

    Dec 1, 2025, 00:00

  • EE531 Impact Of Dupilumab Treatment on Work-Related Medical Leave In Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study

    Dec 1, 2025, 00:00

  • MT37 Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting

    Dec 1, 2025, 00:00

  • EE281 Costing Analysis for the Management of Localized Renal Cell Carcinoma From the UK NHS Perspective

    Dec 1, 2025, 00:00

  • EE571 Management of Moderate-to-Highly Exuding Leg Ulcers with Polyacrylate Dressings vs. Foam Dressings in Spanish Settings: An Early Stage Cost-Effectiveness and Budget-Impact Analysis

    Dec 1, 2025, 00:00

  • EE335 Disability-Associated Economic Burden Among Patients With Wilson’s Disease in South Korea: A Nationwide Cost-of-Illness Study

    Dec 1, 2025, 00:00

  • EE366 Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review

    Dec 1, 2025, 00:00

  • HPR52 Current Status of Home-Healthcare Pilot Programs in South Korea and Policy Discussions for Institutionalization

    Dec 1, 2025, 00:00

  • SA36 Economic Burden Utilities and Cost-Effectiveness of Perioperative Immunotherapies for Early Stage Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

    Dec 1, 2025, 00:00

  • MSR155 New Developments in the Psychometric Testing of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Questionnaire: Responsiveness and Minimally Important Change

    Dec 1, 2025, 00:00

  • EPH106 Exploring the Broader Value of Adult Respiratory Vaccination Programs in Gree A Public Health Perspective

    Dec 1, 2025, 00:00

  • EPH262 Trends in Hospital Treatment of Follicular Lymphoma in Germany

    Dec 1, 2025, 00:00

  • HTA32 Analysis of Pros Included in the HTA Assessment of Conditionally Approved Oncology Drugs in the UK, Italy, and Germany

    Dec 1, 2025, 00:00

  • MSR92 Evaluating the Conceptual Structure of the Barriers to Preexposure Prophylaxis (PrEP) Access Survey: A Confirmatory Item Factor Analysis

    Dec 1, 2025, 00:00

  • MT13 Defining Decision-Making Criteria for Glaucoma Surgery in Non-Refractory, Moderate to Severe Open-Angle Glaucoma: A Stakeholder Analysis Across Multiple Countries with Distinct Payer Archetypes to Support a Multi-Criteria Decision Anal ...

    Dec 1, 2025, 00:00

  • HTA370 Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform

    Dec 1, 2025, 00:00

  • EE204 Cost-Effectiveness Analysis of Image-Guided Ablation vs. Conventional Ablation in Patients With Recurrent Ventricular Tachycardia: Results From the inEurHeart Trial

    Dec 1, 2025, 00:00

  • MT22 Global Evaluation of Flexible Cysto-Nephroscope Usage Patterns in Percutaneous Nephrolithotomy Procedures

    Dec 1, 2025, 00:00

  • CO71 Development of a New, Adaptable Patient-Reported Outcome Measure of Treatment Satisfaction

    Dec 1, 2025, 00:00

  • EPH178 Pertussis Vaccination and Test Rates in Germany by Asthma-COPD Comorbidity Status: A Healthcare Claims Data Analysis in Germany

    Dec 1, 2025, 00:00

  • HPR153 Orphan Drugs Availability in Israel: A Base for Policy Development

    Dec 1, 2025, 00:00

  • OP19 Qualitative Evaluation of an AI Tool for Opportunistic Detection of Vertebral Fractures in the National Health Service

    Dec 1, 2025, 00:00

  • MSR128 Implementing SISAQOL Recommendations: Insights From Cancer Clinical Trials

    Dec 1, 2025, 00:00

  • CO109 Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer

    Dec 1, 2025, 00:00

  • EE410 Enhancing Healthcare Cost Communication Through Visualization: A Decision Tree Framework

    Dec 1, 2025, 00:00

  • HTA83 Comparing Risk of Bias Assessment Requirements Between the EU JCA and European HTA Agencies

    Dec 1, 2025, 00:00

  • EE316 Danicopan: A Dominant Option for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Residual Hemolytic Anemia in Spain

    Dec 1, 2025, 00:00

  • EE238 Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes

    Dec 1, 2025, 00:00

  • HTA135 Evaluating the Role of Societal Perspectives in the EU Joint Clinical Assessment Framework and in EU-27 Health Technology Assessment Guidelines

    Dec 1, 2025, 00:00

  • EPH136 Impact of RSV Infection on Acute Otitis Media Burden in Young Children Beyond Their First Year of Life in Japan

    Dec 1, 2025, 00:00

  • EPH153 Knowledge and Attitudes Regarding the HPV Vaccine Among Secondary School Students

    Dec 1, 2025, 00:00

  • CO15 Assessing the Clinical Impact of Decreasing Weight in Young Adults Using the Metabo-Reno-Cardiovascular Disease Model©

    Dec 1, 2025, 00:00

  • PCR138 Increased Adherence to Biologic Therapies Leads to Lower All-Cause and Asthma-Related (HCRU) Costs in Severe Asthma

    Dec 1, 2025, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »